L-carnitine as an adjunct treatment for septic shock patients with acute kidney injury: a multicentre, randomized, 2-parallel group, superiority trial
Sepsis is a medical emergency caused by the body reacting dangerously to an infection. When blood pressure drops severely, it becomes septic shock, which can damage vital organs such as the kidneys. This clinical trial is investigating whether a substance called L-carnitine can help critically ill patients recover. L-carnitine is a natural nutrient that helps the body’s cells create energy. Researchers hope that giving extra L-carnitine through a drip will help protect kidney cells and support the body during severe stress. Adults in intensive care with septic shock and kidney injury will receive either L-carnitine or a plain salt-water drip, alongside all standard intensive care treatments. Doctors will monitor whether L-carnitine helps patients survive, reduces the need for kidney dialysis or breathing machines, and helps people leave the hospital sooner.
At a glance
What is this study about?
Sepsis occurs when the body's immune system overreacts to an infection and begins damaging its own tissues. If blood pressure drops to dangerously low levels, it is known as septic shock. This is a life-threatening condition that prevents oxygen and blood from reaching essential organs. The kidneys are especially vulnerable, and many patients in septic shock develop acute kidney injury, meaning their kidneys suddenly stop filtering waste properly.
Patients with septic shock receive intensive care, including antibiotics, fluids, and medicines to raise blood pressure. However, doctors are still searching for ways to protect organs and improve survival. This study is testing an add-on treatment called L-carnitine. L-carnitine is a compound made naturally in the body that helps cells break down fats and produce energy. Scientists believe that giving an extra boost of L-carnitine might help stressed kidney and heart cells survive the severe physical stress of sepsis.
In this trial, patients will be randomly split into two groups. One group will receive L-carnitine through an intravenous drip into a vein. The other group will receive a dummy treatment (a simple salt-water solution known as a placebo). Neither the patients nor their bedside medical team will know which drip is being given. Crucially, everyone in the study continues to receive all standard, life-saving intensive care treatments.
The main goal is to find out whether L-carnitine increases the chance of survival. Researchers will also look at how quickly patients recover, how many days they can live without needing kidney machines (dialysis) or breathing machines (ventilators), and how soon they can safely leave the intensive care unit and go home.
Key takeaways
- The trial tests whether L-carnitine helps adults with septic shock and sudden kidney injury.
- L-carnitine is a natural substance that helps cells produce energy during times of severe stress.
- Patients receive either L-carnitine or a salt-water drip alongside their normal intensive care treatment.
- The study aims to improve survival and reduce the need for dialysis and breathing machines.
- Participation happens entirely in the hospital, and family members are consulted if the patient is too unwell to consent.
Who may be eligible?
This trial is specifically for adults aged 18 and older who have been admitted to hospital with septic shock and sudden kidney injury. Because patients with these conditions are critically unwell, they are treated in hospital intensive care units (ICUs).
Both men and women can be included. The hospital care team will check for signs of severe infection, low blood pressure that requires special medicines, and blood tests showing that the kidneys are under serious strain.
Because patients with septic shock are often unconscious, confused, or on breathing machines, they are usually unable to give consent themselves. In these situations, following strict UK legal and ethical rules, doctors will consult a family member or legal representative before enrolling the patient in the trial.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Aged 18 or older
- Currently admitted to hospital or intensive care
- Diagnosed with septic shock caused by a severe infection
- Showing signs of sudden kidney damage (acute kidney injury)
- Receiving treatments to support blood pressure
What does participation involve?
Taking part in this study happens entirely while the patient is being cared for in hospital. A computer randomly assigns the patient to receive either L-carnitine or a salt-water placebo through a standard intravenous drip. The medicine is given alongside all normal intensive care treatments, such as antibiotics, fluids, and oxygen. The medical team will closely monitor the patient’s heart rate, blood pressure, kidney function, and blood tests around the clock. The research team will track how long the patient needs life support, such as kidney dialysis or a breathing machine. After leaving intensive care, researchers will follow the patient's medical notes until they are discharged from hospital, and check on their health status over the following months to see how well they have recovered.
Potential risks and benefits
Locations (1)
- —UnverifiedFrance
Common questions
What is L-carnitine?
L-carnitine is a natural compound found in red meat and dairy foods, and your body also makes it. It helps your cells turn fats into energy.
Will taking part delay standard emergency treatment?
No. All patients receive full, standard intensive care treatments immediately, including antibiotics and fluids. The trial treatment is added on top.
Why is a placebo used in this study?
A placebo (a harmless salt-water drip) allows researchers to fairly compare the results and be sure whether any improvements are truly caused by L-carnitine.
Can family members make decisions about joining?
Yes. In UK emergency research, if a patient is too ill to speak for themselves, doctors will ask their family or a legal representative for permission.
Does taking part cost anything?
No. All study medications and tests are provided free of charge as part of hospital care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.